Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Micieli, G; Cavallini, A; Marcheselli, S; Mailland, F; Ambrosoli, L; Nappi, G
   Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis
   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
   
   G. Micieli et al., "Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis", INT J CL PH, 39(4), 2001, pp. 144-151
2. Bundgaard, H; von Oettingen, G; Jorgensen, HA; Jensen, K; Cold, GE
   Effects of dihydroergotamine on intracranial pressure, cerebral blood flow, and cerebral metabolism in patients undergoing craniotomy for brain tumors
   JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY
   
   H. Bundgaard et al., "Effects of dihydroergotamine on intracranial pressure, cerebral blood flow, and cerebral metabolism in patients undergoing craniotomy for brain tumors", J NEUROS AN, 13(3), 2001, pp. 195-201
3. Stahl, N; Ungerstedt, U; Nordstrom, CH
   Brain energy metabolism during controlled reduction of cerebral perfusion pressure in severe head injuries
   INTENSIVE CARE MEDICINE
   
   N. Stahl et al., "Brain energy metabolism during controlled reduction of cerebral perfusion pressure in severe head injuries", INTEN CAR M, 27(7), 2001, pp. 1215-1223
4. de Hoon, JNJM; Poppe, KA; Thijssen, HHW; Struijker-Boudier, HAJ; Van Bortel, LMAB
   Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
   
   J.N.J.M. de Hoon et al., "Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data", BR J CL PH, 52(1), 2001, pp. 45-51
5. Zakrzewska, JM
   Cluster headache: review of the literature
   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
   
   J.M. Zakrzewska, "Cluster headache: review of the literature", BR J ORAL M, 39(2), 2001, pp. 103-113
6. Koch, A; Ziegler, S; Breitschwerdt, H; Victor, N
   Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: Meta-analysis based on original patient data
   THROMBOSIS RESEARCH
   
   A. Koch et al., "Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: Meta-analysis based on original patient data", THROMB RES, 102(4), 2001, pp. 295-309
7. Schoning, C; Flieger, M; Pertz, HH
   Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha(1) receptors in isolated arteries of rat and guinea pig
   JOURNAL OF ANIMAL SCIENCE
   
   C. Schoning et al., "Complex interaction of ergovaline with 5-HT2A, 5-HT1B/1D, and alpha(1) receptors in isolated arteries of rat and guinea pig", J ANIM SCI, 79(8), 2001, pp. 2202-2209
8. Worthington, I
   Delivery systems for acute migraine medications
   CANADIAN FAMILY PHYSICIAN
   
   I. Worthington, "Delivery systems for acute migraine medications", CAN FAM PHY, 47, 2001, pp. 322-329
9. Centurion, D; Ortiz, MI; Sanchez-Lopez, A; De Vries, P; Saxena, PR; Villalon, CM
   Evidence for 5-HT1B/1D and 5-HT2A receptors mediating constriction of the canine internal carotid circulation
   BRITISH JOURNAL OF PHARMACOLOGY
   
   D. Centurion et al., "Evidence for 5-HT1B/1D and 5-HT2A receptors mediating constriction of the canine internal carotid circulation", BR J PHARM, 132(5), 2001, pp. 983-990
10. Critchley, LAH; Woodward, DK
    Haemodynamic effects of three doses of dihydroergotamine during spinal anaesthesia
    BRITISH JOURNAL OF ANAESTHESIA
    
    L.A.H. Critchley e D.K. Woodward, "Haemodynamic effects of three doses of dihydroergotamine during spinal anaesthesia", BR J ANAEST, 87(3), 2001, pp. 499-501
11. Kelly, AM
    Migraine: pharmacotherapy in the emergency department
    JOURNAL OF ACCIDENT & EMERGENCY MEDICINE
    
    A.M. Kelly, "Migraine: pharmacotherapy in the emergency department", J AC EMER M, 17(4), 2000, pp. 241-245
12. Damas, F; Hans, P
    Management of the severely head-injured patient within the first 24 hours.Specific therapeutic measures.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    
    F. Damas e P. Hans, "Management of the severely head-injured patient within the first 24 hours.Specific therapeutic measures.", ANN FR A R, 19(4), 2000, pp. 326-332
13. Pradalier, A; Baudesson, G; Delage, A
    Acute treatment of the migraine attack.
    PATHOLOGIE BIOLOGIE
    
    A. Pradalier et al., "Acute treatment of the migraine attack.", PATH BIOL, 48(7), 2000, pp. 679-689
14. Krymchantowski, AV; Barbosa, JS
    Prednisone as initial treatment of analgesic-induced daily headache
    CEPHALALGIA
    
    A.V. Krymchantowski e J.S. Barbosa, "Prednisone as initial treatment of analgesic-induced daily headache", CEPHALALGIA, 20(2), 2000, pp. 107-113
15. Silberstein, SD; McCrory, DC
    Opioids
    CEPHALALGIA
    
    S.D. Silberstein e D.C. McCrory, "Opioids", CEPHALALGIA, 20(10), 2000, pp. 854-864
16. Eker, C; Schalen, W; Asgeirsson, B; Grande, PO; Ranstam, J; Nordstrom, CH
    Reduced mortality after severe head injury will increase the demands for rehabilitation sevices
    BRAIN INJURY
    
    C. Eker et al., "Reduced mortality after severe head injury will increase the demands for rehabilitation sevices", BRAIN INJUR, 14(7), 2000, pp. 605-619
17. Kelly, AM
    Migraine: pharmacotherapy in the emergency department
    WESTERN JOURNAL OF MEDICINE
    
    A.M. Kelly, "Migraine: pharmacotherapy in the emergency department", WEST J MED, 173(3), 2000, pp. 189-193
18. Lance, JW
    2: Headache and face pain
    MEDICAL JOURNAL OF AUSTRALIA
    
    J.W. Lance, "2: Headache and face pain", MED J AUST, 172(9), 2000, pp. 450-455
19. Lu, SR; Fuh, JL; Juang, KD; Wang, SJ
    Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache
    HEADACHE
    
    S.R. Lu et al., "Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache", HEADACHE, 40(9), 2000, pp. 724-729
20. McBeath, JG; Nanda, A
    Roller coaster migraine: An underreported injury?
    HEADACHE
    
    J.G. McBeath e A. Nanda, "Roller coaster migraine: An underreported injury?", HEADACHE, 40(9), 2000, pp. 745-747
21. Young, WB; Mannix, L; Adelman, JU; Shechter, AL
    Cardiac risk factors and the use of triptans: A survey study
    HEADACHE
    
    W.B. Young et al., "Cardiac risk factors and the use of triptans: A survey study", HEADACHE, 40(7), 2000, pp. 587-591
22. Pradalier, A; Lutz, G; Vincent, D
    Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan
    HEADACHE
    
    A. Pradalier et al., "Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan", HEADACHE, 40(4), 2000, pp. 324-327
23. Redillas, C; Solomon, S
    Prophylactic pharmacological treatment of chronic daily headache
    HEADACHE
    
    C. Redillas e S. Solomon, "Prophylactic pharmacological treatment of chronic daily headache", HEADACHE, 40(2), 2000, pp. 83-102
24. Tfelt-Hansen, P; Saxena, PR; Dahlof, C; Pascual, J; Lainez, M; Henry, P; Diener, HC; Schoenen, J; Ferrari, MD; Goadsby, PJ
    Ergotamine in the acute treatment of migraine - A review and European consensus
    BRAIN
    
    P. Tfelt-Hansen et al., "Ergotamine in the acute treatment of migraine - A review and European consensus", BRAIN, 123, 2000, pp. 9-18
25. Logemann, CD; Rankin, LM
    Newer intranasal migraine medications
    AMERICAN FAMILY PHYSICIAN
    
    C.D. Logemann e L.M. Rankin, "Newer intranasal migraine medications", AM FAM PHYS, 61(1), 2000, pp. 180-186
26. Murday, M; McLean, AM; Slaughter, E; Couch, RA
    Determination of dihydroergotamine in human plasma by high-performance liquid chromatography with fluorescence detection
    JOURNAL OF CHROMATOGRAPHY B
    
    M. Murday et al., "Determination of dihydroergotamine in human plasma by high-performance liquid chromatography with fluorescence detection", J CHROMAT B, 735(2), 1999, pp. 151-157
27. Zed, PJ; Loewen, PS; Robinson, G
    Medication-induced headache: Overview and systematic review of therapeuticapproaches
    ANNALS OF PHARMACOTHERAPY
    
    P.J. Zed et al., "Medication-induced headache: Overview and systematic review of therapeuticapproaches", ANN PHARMAC, 33(1), 1999, pp. 61-72
28. Alexander, P; Giangola, G
    Deep venous thrombosis and pulmonary embolism: Diagnosis, prophylaxis, andtreatment
    ANNALS OF VASCULAR SURGERY
    
    P. Alexander e G. Giangola, "Deep venous thrombosis and pulmonary embolism: Diagnosis, prophylaxis, andtreatment", ANN VASC S, 13(3), 1999, pp. 318-327
29. Ducharme, J
    Canadian Association of Emergency Physicians Guidelines for the acute management of migraine headache
    JOURNAL OF EMERGENCY MEDICINE
    
    J. Ducharme, "Canadian Association of Emergency Physicians Guidelines for the acute management of migraine headache", J EMERG MED, 17(1), 1999, pp. 137-144
30. Triner, WR; Bartfield, JM; Birdwell, M; Raccio-Robak, N
    Nitrous oxide for the treatment of acute migraine headache
    AMERICAN JOURNAL OF EMERGENCY MEDICINE
    
    W.R. Triner et al., "Nitrous oxide for the treatment of acute migraine headache", AM J EMER M, 17(3), 1999, pp. 252-254
31. Cerbo, R; Pascali, MP; Barbanti, P; Buzzi, MG
    Cluster headache: management of acute attacks before triptans
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    R. Cerbo et al., "Cluster headache: management of acute attacks before triptans", ITAL J NEUR, 20(2), 1999, pp. S63-S65
32. Weitzel, KW; Thomas, ML; Small, RE; Goode, JVR
    Migraine: A comprehensive review of new treatment options
    PHARMACOTHERAPY
    
    K.W. Weitzel et al., "Migraine: A comprehensive review of new treatment options", PHARMACOTHE, 19(8), 1999, pp. 957-973
33. Lobo, BL; Cooke, SC; Landy, SH
    Symptomatic pharmacotherapy of migraine
    CLINICAL THERAPEUTICS
    
    B.L. Lobo et al., "Symptomatic pharmacotherapy of migraine", CLIN THER, 21(7), 1999, pp. 1118-1130
34. van der Kuy, PHM; Lohman, JJHM; Hooymans, PM; Ter Berg, JWM; Merkus, FWHM
    Bioavailability of intranasal formulations of dihydroergotamine
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    P.H.M. van der Kuy et al., "Bioavailability of intranasal formulations of dihydroergotamine", EUR J CL PH, 55(9), 1999, pp. 677-680
35. Bussone, G; Cerbo, R; Martucci, N; Micieli, G; Zanferrari, C; Grazzi, L; Fabbrini, G; Cavallini, A; Granella, F; Ambrosoli, L; Mailland, F; Poli, A; Manzoni, G
    alpha-dihydroergocryptine in the prophylaxis of migraine: A multicenter double-blind study versus flunarizine
    HEADACHE
    
    G. Bussone et al., "alpha-dihydroergocryptine in the prophylaxis of migraine: A multicenter double-blind study versus flunarizine", HEADACHE, 39(6), 1999, pp. 426-431
36. Young, WB
    Death by managed care - Denial of hospitalization for headache
    HEADACHE
    
    W.B. Young, "Death by managed care - Denial of hospitalization for headache", HEADACHE, 39(1), 1999, pp. 51-54
37. Assie, MB; Cosi, C; Koek, W
    Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    M.B. Assie et al., "Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity", EUR J PHARM, 386(1), 1999, pp. 97-103
38. Villalon, CM; De Vries, P; Rabelo, G; Centurion, D; Sanchez-Lopez, A; Saxena, P
    Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha(2)-adrenoceptors
    BRITISH JOURNAL OF PHARMACOLOGY
    
    C.M. Villalon et al., "Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha(2)-adrenoceptors", BR J PHARM, 126(3), 1999, pp. 585-594
39. Evers, S; Schmidt, F; Bauer, B; Voss, H; Grotemeyer, KH; Husstedt, IW
    The impact of ergotamine induced headache and ergotamine withdrawal on information processing
    PSYCHOPHARMACOLOGY
    
    S. Evers et al., "The impact of ergotamine induced headache and ergotamine withdrawal on information processing", PSYCHOPHAR, 142(1), 1999, pp. 61-67
40. WINNER PK
    MIGRAINE - DIAGNOSIS AND RATIONAL TREATMENT
    International journal of fertility and women's medicine
    
    P.K. Winner, "MIGRAINE - DIAGNOSIS AND RATIONAL TREATMENT", International journal of fertility and women's medicine, 43(2), 1998, pp. 104-110
41. DEWEY RB; RAO SD; HOLMBURG SL; VICTOR RG
    ERGOTAMINE CAFFEINE TREATMENT OF ORTHOSTATIC HYPOTENSION IN PARKINSONISM WITH AUTONOMIC FAILURE/
    European journal of neurology
    
    R.B. Dewey et al., "ERGOTAMINE CAFFEINE TREATMENT OF ORTHOSTATIC HYPOTENSION IN PARKINSONISM WITH AUTONOMIC FAILURE/", European journal of neurology, 5(6), 1998, pp. 593-599
42. YOUNG WB; SILBERSTEIN SD; ROZEN TD
    MANAGEMENT OF MIGRAINE - OPPORTUNITY OR BOTTOMLESS PIT
    American journal of managed care
    
    W.B. Young et al., "MANAGEMENT OF MIGRAINE - OPPORTUNITY OR BOTTOMLESS PIT", American journal of managed care, 4(10), 1998, pp. 637-647
43. DUCHARME J; BEVERIDGE RC; LEE JS; BEAULIEU S
    EMERGENCY MANAGEMENT OF MIGRAINE - IS THE HEADACHE REALLY OVER
    Academic emergency medicine
    
    J. Ducharme et al., "EMERGENCY MANAGEMENT OF MIGRAINE - IS THE HEADACHE REALLY OVER", Academic emergency medicine, 5(9), 1998, pp. 899-905
44. WARD TN
    MANAGEMENT OF AN ACUTE PRIMARY HEADACHE
    Clinical neuroscience
    
    T.N. Ward, "MANAGEMENT OF AN ACUTE PRIMARY HEADACHE", Clinical neuroscience, 5(1), 1998, pp. 50-54
45. BONAVENTURE P; VOORN P; LUYTEN WHML; LEYSEN JE
    5HT(1B) AND 5HT(1D) RECEPTOR MESSENGER-RNA DIFFERENTIAL COLOCALIZATION WITH PEPTIDE MESSENGER-RNA IN THE GUINEA-PIG TRIGEMINAL GANGLION
    NeuroReport
    
    P. Bonaventure et al., "5HT(1B) AND 5HT(1D) RECEPTOR MESSENGER-RNA DIFFERENTIAL COLOCALIZATION WITH PEPTIDE MESSENGER-RNA IN THE GUINEA-PIG TRIGEMINAL GANGLION", NeuroReport, 9(4), 1998, pp. 641-645
46. VALENTIN JP; BONNAFOUS R; JOHN GW
    CONTRACTILE RESPONSES EVOKED BY DIHYDROERGOTAMINE, NARATRIPTAN AND SUMATRIPTAN IN THE CANINE ISOLATED CORONARY-ARTERY
    Fundamental and clinical pharmacology
    
    J.P. Valentin et al., "CONTRACTILE RESPONSES EVOKED BY DIHYDROERGOTAMINE, NARATRIPTAN AND SUMATRIPTAN IN THE CANINE ISOLATED CORONARY-ARTERY", Fundamental and clinical pharmacology, 12(2), 1998, pp. 152-157
47. TSUTSUMI K; OBATA Y; TAKAYAMA K; LOFTSSON T; NAGAI T
    EFFECT OF COD-LIVER OIL EXTRACT ON THE BUCCAL PERMEATION OF ERGOTAMINE TARTRATE
    Drug development and industrial pharmacy
    
    K. Tsutsumi et al., "EFFECT OF COD-LIVER OIL EXTRACT ON THE BUCCAL PERMEATION OF ERGOTAMINE TARTRATE", Drug development and industrial pharmacy, 24(8), 1998, pp. 757-762
48. DELEU D; HANSSENS F; WORTHING EA
    SYMPTOMATIC AND PROPHYLACTIC TREATMENT OF MIGRAINE - A CRITICAL REAPPRAISAL
    Clinical neuropharmacology
    
    D. Deleu et al., "SYMPTOMATIC AND PROPHYLACTIC TREATMENT OF MIGRAINE - A CRITICAL REAPPRAISAL", Clinical neuropharmacology, 21(5), 1998, pp. 267-279
49. NAREDI S; EDEN E; ZALL S; STEPHENSEN H; RYDENHAG B
    A STANDARDIZED NEUROSURGICAL NEUROINTENSIVE THERAPY DIRECTED TOWARD VASOGENIC EDEMA AFTER SEVERE TRAUMATIC BRAIN INJURY - CLINICAL-RESULTS/
    Intensive care medicine
    
    S. Naredi et al., "A STANDARDIZED NEUROSURGICAL NEUROINTENSIVE THERAPY DIRECTED TOWARD VASOGENIC EDEMA AFTER SEVERE TRAUMATIC BRAIN INJURY - CLINICAL-RESULTS/", Intensive care medicine, 24(5), 1998, pp. 446-451
50. TFELTHANSEN P
    EFFICACY AND ADVERSE EVENTS OF SUBCUTANEOUS, ORAL, AND INTRANASAL SUMATRIPTAN USED FOR MIGRAINE TREATMENT - A SYSTEMATIC REVIEW BASED ON NUMBER NEEDED TO TREAT
    Cephalalgia
    
    P. Tfelthansen, "EFFICACY AND ADVERSE EVENTS OF SUBCUTANEOUS, ORAL, AND INTRANASAL SUMATRIPTAN USED FOR MIGRAINE TREATMENT - A SYSTEMATIC REVIEW BASED ON NUMBER NEEDED TO TREAT", Cephalalgia, 18(8), 1998, pp. 532-538
51. VRAAMARK T; WALDEMAR G; PAULSON OB
    DIFFERENTIAL-EFFECTS OF MIGRAINE DRUGS ON CEREBRAL BLOOD-FLOW AUTOREGULATION
    Cephalalgia
    
    T. Vraamark et al., "DIFFERENTIAL-EFFECTS OF MIGRAINE DRUGS ON CEREBRAL BLOOD-FLOW AUTOREGULATION", Cephalalgia, 18(6), 1998, pp. 306-312
52. HOLDEN EW; LEVY JD; DEICHMANN MM; GLADSTEIN J
    RECURRENT PEDIATRIC HEADACHES - ASSESSMENT AND INTERVENTION
    Journal of developmental and behavioral pediatrics
    
    E.W. Holden et al., "RECURRENT PEDIATRIC HEADACHES - ASSESSMENT AND INTERVENTION", Journal of developmental and behavioral pediatrics, 19(2), 1998, pp. 109-116
53. CARLETON SC; SHESSER RF; PIETRZAK MP; CHUDNOFSKY CR; STARKMAN S; MORRIS DL; JOHNSON G; RHEE KJ; BARTON CW; CHELLY JE; ROSENBERG J; VANVALEN MK
    DOUBLE-BLIND, MULTICENTER TRIAL TO COMPARE THE EFFICACY OF INTRAMUSCULAR DIHYDROERGOTAMINE PLUS HYDROXYZINE VERSUS INTRAMUSCULAR MEPERIDINEPLUS HYDROXYZINE FOR THE EMERGENCY DEPARTMENT TREATMENT OF ACUTE MIGRAINE HEADACHE
    Annals of emergency medicine
    
    S.C. Carleton et al., "DOUBLE-BLIND, MULTICENTER TRIAL TO COMPARE THE EFFICACY OF INTRAMUSCULAR DIHYDROERGOTAMINE PLUS HYDROXYZINE VERSUS INTRAMUSCULAR MEPERIDINEPLUS HYDROXYZINE FOR THE EMERGENCY DEPARTMENT TREATMENT OF ACUTE MIGRAINE HEADACHE", Annals of emergency medicine, 32(2), 1998, pp. 129-138
54. SOMMER S; DELEMAZURE B; WAGNER M; XENARD L; ROZOT P
    BILATERAL ISCHEMIC OPTIC NEUROPATHY DUE T O ERGOTISM
    Journal francais d'ophtalmologie
    
    S. Sommer et al., "BILATERAL ISCHEMIC OPTIC NEUROPATHY DUE T O ERGOTISM", Journal francais d'ophtalmologie, 21(2), 1998, pp. 123-125
55. Wang, YF; Aun, R; Tse, FLS
    Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat
    BIOPHARMACEUTICS & DRUG DISPOSITION
    
    Y.F. Wang et al., "Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat", BIOPHARM DR, 19(9), 1998, pp. 571-575
56. FERRARI MD
    MIGRAINE
    Lancet
    
    M.D. Ferrari, "MIGRAINE", Lancet, 351(9108), 1998, pp. 1043-1051
57. MAIZELS M
    THE CLINICIAN APPROACH TO THE MANAGEMENT OF HEADACHE
    Western journal of medicine
    
    M. Maizels, "THE CLINICIAN APPROACH TO THE MANAGEMENT OF HEADACHE", Western journal of medicine, 168(3), 1998, pp. 203-212
58. EKER C; ASGEIRSSON B; GRANDE PO; SCHALEN W; NORDSTROM CH
    IMPROVED OUTCOME AFTER SEVERE HEAD-INJURY WITH A NEW THERAPY BASED ONPRINCIPLES FOR BRAIN VOLUME REGULATION AND PRESERVED MICROCIRCULATION
    Critical care medicine
    
    C. Eker et al., "IMPROVED OUTCOME AFTER SEVERE HEAD-INJURY WITH A NEW THERAPY BASED ONPRINCIPLES FOR BRAIN VOLUME REGULATION AND PRESERVED MICROCIRCULATION", Critical care medicine, 26(11), 1998, pp. 1881-1886
59. GOADSBY PJ
    A TRIPTAN TOO FAR
    Journal of Neurology, Neurosurgery and Psychiatry
    
    P.J. Goadsby, "A TRIPTAN TOO FAR", Journal of Neurology, Neurosurgery and Psychiatry, 64(2), 1998, pp. 143-147
60. NIGHOGHOSSIAN N; DEREX L; TROUILLAS P
    MULTIPLE INTRACEREBRAL HEMORRHAGES AND VASOSPASM FOLLOWING ANTIMIGRAINOUS DRUG-ABUSE
    Headache
    
    N. Nighoghossian et al., "MULTIPLE INTRACEREBRAL HEMORRHAGES AND VASOSPASM FOLLOWING ANTIMIGRAINOUS DRUG-ABUSE", Headache, 38(6), 1998, pp. 478-480
61. FINKEL AG; HOWARD JF; MANN JD
    SUCCESSFUL TREATMENT OF HEADACHE RELATED TO INTRAVENOUS IMMUNOGLOBULIN WITH ANTIMIGRAINE MEDICATIONS
    Headache
    
    A.G. Finkel et al., "SUCCESSFUL TREATMENT OF HEADACHE RELATED TO INTRAVENOUS IMMUNOGLOBULIN WITH ANTIMIGRAINE MEDICATIONS", Headache, 38(4), 1998, pp. 317-321
62. Haase, CG; Diener, HC
    Transcranial Doppler ultrasonographic features during drug withdrawal fromdrug-induced headache. A transcranial Doppler follow-up study
    HEADACHE
    
    C.G. Haase e H.C. Diener, "Transcranial Doppler ultrasonographic features during drug withdrawal fromdrug-induced headache. A transcranial Doppler follow-up study", HEADACHE, 38(9), 1998, pp. 679-683
63. Drucker, P; Tepper, S
    Daily sumatriptan for detoxification from rebound
    HEADACHE
    
    P. Drucker e S. Tepper, "Daily sumatriptan for detoxification from rebound", HEADACHE, 38(9), 1998, pp. 687-690
64. Treves, TA; Kuritzky, A; Hering, R; Korczyn, AD
    Dihydroergotamine nasal spray in the treatment of acute migraine
    HEADACHE
    
    T.A. Treves et al., "Dihydroergotamine nasal spray in the treatment of acute migraine", HEADACHE, 38(8), 1998, pp. 614-617
65. HAHNE T; BALDA BR
    FINGERTIP NECROSIS AFTER DIHYDROERGOTAMINE MEDICATION IN LIMITED SYSTEMIC SCLERODERMA
    Hautarzt
    
    T. Hahne e B.R. Balda, "FINGERTIP NECROSIS AFTER DIHYDROERGOTAMINE MEDICATION IN LIMITED SYSTEMIC SCLERODERMA", Hautarzt, 49(9), 1998, pp. 722-724
66. HOSKIN KL; GOADSBY PJ
    COMPARISON OF MORE AND LESS LIPOPHILIC SEROTONIN (5HT(1B 1D)) AGONISTS IN A MODEL OF TRIGEMINOVASCULAR NOCICEPTION IN CAT/
    Experimental neurology
    
    K.L. Hoskin e P.J. Goadsby, "COMPARISON OF MORE AND LESS LIPOPHILIC SEROTONIN (5HT(1B 1D)) AGONISTS IN A MODEL OF TRIGEMINOVASCULAR NOCICEPTION IN CAT/", Experimental neurology, 150(1), 1998, pp. 45-51
67. DEVRIES P; VILLALON CM; HEILIGERS JPC; SAXENA PR
    CHARACTERIZATION OF 5-HT RECEPTORS MEDIATING CONSTRICTION OF PORCINE CAROTID ARTERIOVENOUS ANASTOMOSES - INVOLVEMENT OF 5HT(1B 1D) AND NOVEL RECEPTORS/
    British Journal of Pharmacology
    
    P. Devries et al., "CHARACTERIZATION OF 5-HT RECEPTORS MEDIATING CONSTRICTION OF PORCINE CAROTID ARTERIOVENOUS ANASTOMOSES - INVOLVEMENT OF 5HT(1B 1D) AND NOVEL RECEPTORS/", British Journal of Pharmacology, 123(8), 1998, pp. 1561-1570
68. LESAGE AS; WOUTERS R; VANGOMPEL P; HEYLEN L; VANHOENACKER P; HAEGEMAN G; LUYTEN WHML; LEYSEN JE
    AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES
    British Journal of Pharmacology
    
    A.S. Lesage et al., "AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES", British Journal of Pharmacology, 123(8), 1998, pp. 1655-1665
69. GOLD L; BACK T; ARNOLD G; DREIER J; EINHAUPL KM; REUTER U; DIRNAGL U
    CORTICAL SPREADING DEPRESSION-ASSOCIATED HYPEREMIA IN RATS - INVOLVEMENT OF SEROTONIN
    Brain research
    
    L. Gold et al., "CORTICAL SPREADING DEPRESSION-ASSOCIATED HYPEREMIA IN RATS - INVOLVEMENT OF SEROTONIN", Brain research, 783(2), 1998, pp. 188-193
70. ARNDT JO; BOMER W; KRAUTH J; MARQUARDT B
    INCIDENCE AND TIME-COURSE OF CARDIOVASCULAR SIDE-EFFECTS DURING SPINAL-ANESTHESIA AFTER PROPHYLACTIC ADMINISTRATION OF INTRAVENOUS FLUIDS OR VASOCONSTRICTORS
    Anesthesia and analgesia
    
    J.O. Arndt et al., "INCIDENCE AND TIME-COURSE OF CARDIOVASCULAR SIDE-EFFECTS DURING SPINAL-ANESTHESIA AFTER PROPHYLACTIC ADMINISTRATION OF INTRAVENOUS FLUIDS OR VASOCONSTRICTORS", Anesthesia and analgesia, 87(2), 1998, pp. 347-354
71. ROMEIJN SG; MARTTIN E; VERHOEF JC; MERKUS FWHM
    SIMPLIFIED SOLID-PHASE EXTRACTION METHOD FOR DETERMINATION OF DIHYDROERGOTAMINE IN RABBIT AND HUMAN SERUM USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
    Journal of chromatography B. Biomedical sciences and applications
    
    S.G. Romeijn et al., "SIMPLIFIED SOLID-PHASE EXTRACTION METHOD FOR DETERMINATION OF DIHYDROERGOTAMINE IN RABBIT AND HUMAN SERUM USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION", Journal of chromatography B. Biomedical sciences and applications, 692(1), 1997, pp. 227-232
72. RAPOPORT AM; SHEFTELL FD
    INTRANASAL MEDICATIONS FOR THE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE
    CNS DRUGS
    
    A.M. Rapoport e F.D. Sheftell, "INTRANASAL MEDICATIONS FOR THE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE", CNS DRUGS, 7(1), 1997, pp. 37-46
73. PLATH J; SCHULZE R; BARZ D; KRAMMER B; STEINER M; ANDERS O; MACH J
    NECROTIZING SKIN-LESIONS INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN AFTER TOTAL KNEE ARTHROPLASTY
    Archives of orthopaedic and trauma surgery
    
    J. Plath et al., "NECROTIZING SKIN-LESIONS INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN AFTER TOTAL KNEE ARTHROPLASTY", Archives of orthopaedic and trauma surgery, 116(6-7), 1997, pp. 443-445
74. ANSARI S; WARWICK D; ACKROYD CE; NEWMAN JH
    INCIDENCE OF FATAL PULMONARY-EMBOLISM AFTER 1,390 KNEE ARTHROPLASTIESWITHOUT ROUTINE PROPHYLACTIC ANTICOAGULATION, EXCEPT IN HIGH-RISK CASES
    The Journal of arthroplasty
    
    S. Ansari et al., "INCIDENCE OF FATAL PULMONARY-EMBOLISM AFTER 1,390 KNEE ARTHROPLASTIESWITHOUT ROUTINE PROPHYLACTIC ANTICOAGULATION, EXCEPT IN HIGH-RISK CASES", The Journal of arthroplasty, 12(6), 1997, pp. 599-602
75. BRACCO D; BISSONNETTE B; FAVRE JB; MOESCHLER O; BOULARD G; RAVUSSIN P
    CEREBRAL HEMODYNAMICS AND INTRACRANIAL HY PERTENSIONS
    Annales francaises d'anesthesie et de reanimation
    
    D. Bracco et al., "CEREBRAL HEMODYNAMICS AND INTRACRANIAL HY PERTENSIONS", Annales francaises d'anesthesie et de reanimation, 16(4), 1997, pp. 429-434
76. MATHEW NT
    SEROTONIN 1(D) (5-HT1D) AGONISTS AND OTHER AGENTS IN ACUTE MIGRAINE
    Neurologic clinics
    
    N.T. Mathew, "SEROTONIN 1(D) (5-HT1D) AGONISTS AND OTHER AGENTS IN ACUTE MIGRAINE", Neurologic clinics, 15(1), 1997, pp. 61
77. GOADSBY PJ; KNIGHT YE
    DIRECT EVIDENCE FOR CENTRAL SITES OF ACTION OF ZOLMITRIPTAN (311C90) - AN AUTORADIOGRAPHIC STUDY IN CAT
    Cephalalgia
    
    P.J. Goadsby e Y.E. Knight, "DIRECT EVIDENCE FOR CENTRAL SITES OF ACTION OF ZOLMITRIPTAN (311C90) - AN AUTORADIOGRAPHIC STUDY IN CAT", Cephalalgia, 17(3), 1997, pp. 153-158
78. MATHEW N
    ZOLMITRIPTAN - FROM DRUG DESIGN TO CLINICAL-PRACTICE - INTRODUCTION
    Cephalalgia
    
    N. Mathew, "ZOLMITRIPTAN - FROM DRUG DESIGN TO CLINICAL-PRACTICE - INTRODUCTION", Cephalalgia, 17, 1997, pp. 1-3
79. PALMER AJ; SCHRAMM W; KIRCHHOF B; BERGEMANN R
    LOW-MOLECULAR-WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN FOR PREVENTION OF THROMBOEMBOLISM IN GENERAL-SURGERY - A METAANALYSIS OF RANDOMIZEDCLINICAL-TRIALS
    Haemostasis
    
    A.J. Palmer et al., "LOW-MOLECULAR-WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN FOR PREVENTION OF THROMBOEMBOLISM IN GENERAL-SURGERY - A METAANALYSIS OF RANDOMIZEDCLINICAL-TRIALS", Haemostasis, 27(2), 1997, pp. 65-74
80. SWAIN RA; KAPLAN B
    DIAGNOSIS, PROPHYLAXIS, AND TREATMENT OF HEADACHES IN THE ATHLETE
    Southern medical journal
    
    R.A. Swain e B. Kaplan, "DIAGNOSIS, PROPHYLAXIS, AND TREATMENT OF HEADACHES IN THE ATHLETE", Southern medical journal, 90(9), 1997, pp. 878-888
81. FORD RG; FORD KT
    CONTINUOUS INTRAVENOUS DIHYDROERGOTAMINE IN THE TREATMENT OF INTRACTABLE HEADACHE
    Headache
    
    R.G. Ford e K.T. Ford, "CONTINUOUS INTRAVENOUS DIHYDROERGOTAMINE IN THE TREATMENT OF INTRACTABLE HEADACHE", Headache, 37(3), 1997, pp. 129-136
82. SAPER JR
    DIAGNOSIS AND SYMPTOMATIC TREATMENT OF MIGRAINE
    Headache
    
    J.R. Saper, "DIAGNOSIS AND SYMPTOMATIC TREATMENT OF MIGRAINE", Headache, 37, 1997, pp. 1-14
83. SILBERSTEIN SD
    THE PHARMACOLOGY OF ERGOTAMINE AND DIHYDROERGOTAMINE
    Headache
    
    S.D. Silberstein, "THE PHARMACOLOGY OF ERGOTAMINE AND DIHYDROERGOTAMINE", Headache, 37, 1997, pp. 15-25
84. MATHEW NT
    DOSING AND ADMINISTRATION OF ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE
    Headache
    
    N.T. Mathew, "DOSING AND ADMINISTRATION OF ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE", Headache, 37, 1997, pp. 26-32
85. LIPTON RB
    ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE MESYLATE - SAFETY PROFILES
    Headache
    
    R.B. Lipton, "ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE MESYLATE - SAFETY PROFILES", Headache, 37, 1997, pp. 33-41
86. YOUNG WB
    APPROPRIATE USE OF ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE IN THE TREATMENT OF MIGRAINE - CURRENT PERSPECTIVES
    Headache
    
    W.B. Young, "APPROPRIATE USE OF ERGOTAMINE TARTRATE AND DIHYDROERGOTAMINE IN THE TREATMENT OF MIGRAINE - CURRENT PERSPECTIVES", Headache, 37, 1997, pp. 42-45
87. EDMEADS JG; GAWEL MJ; VICKERS J
    STRATEGIES FOR DIAGNOSING AND MANAGING MEDICATION-INDUCED HEADACHE
    Canadian family physician
    
    J.G. Edmeads et al., "STRATEGIES FOR DIAGNOSING AND MANAGING MEDICATION-INDUCED HEADACHE", Canadian family physician, 43, 1997, pp. 1249-1254
88. NILSSON F; NILSSON T; EDVINSSON L; BJORKMAN S; NORDSTROM CH
    EFFECTS OF DIHYDROERGOTAMINE AND SUMATRIPTAN ON ISOLATED HUMAN CEREBRAL AND PERIPHERAL ARTERIES AND VEINS
    Acta anaesthesiologica Scandinavica
    
    F. Nilsson et al., "EFFECTS OF DIHYDROERGOTAMINE AND SUMATRIPTAN ON ISOLATED HUMAN CEREBRAL AND PERIPHERAL ARTERIES AND VEINS", Acta anaesthesiologica Scandinavica, 41(10), 1997, pp. 1257-1262
89. EZAN E; ARDOUIN T; LANDES BD; FLOUVAT B; HANSLIK T; LEGEAI JM; GROGNET JM
    BIOEQUIVALENCE STUDY OF ALPHA-DIHYDROERGOCRYPTINE - UTILITY OF METABOLITE EVALUATION
    International journal of clinical pharmacology and therapeutics
    
    E. Ezan et al., "BIOEQUIVALENCE STUDY OF ALPHA-DIHYDROERGOCRYPTINE - UTILITY OF METABOLITE EVALUATION", International journal of clinical pharmacology and therapeutics, 34(1), 1996, pp. 32-37
90. JONES J; PACK S; CHUN E
    INTRAMUSCULAR PROCHLORPERAZINE VERSUS METOCLOPRAMIDE AS SINGLE-AGENT THERAPY FOR THE TREATMENT OF ACUTE MIGRAINE HEADACHE
    The American journal of emergency medicine
    
    J. Jones et al., "INTRAMUSCULAR PROCHLORPERAZINE VERSUS METOCLOPRAMIDE AS SINGLE-AGENT THERAPY FOR THE TREATMENT OF ACUTE MIGRAINE HEADACHE", The American journal of emergency medicine, 14(3), 1996, pp. 262-264
91. LIMMROTH V; MAY A; DIENER HC
    THE VALUE OF SUMATRIPTAN IN THE ACUTE TRE ATMENT OF MIGRAINE AND CLUSTER HEADACHE
    Nervenheilkunde
    
    V. Limmroth et al., "THE VALUE OF SUMATRIPTAN IN THE ACUTE TRE ATMENT OF MIGRAINE AND CLUSTER HEADACHE", Nervenheilkunde, 15(2), 1996, pp. 101-109
92. NIAZY EM
    DIFFERENCES IN PENETRATION-ENHANCING EFFECT OF AZONE THROUGH EXCISED RABBIT, RAT, HAIRLESS MOUSE, GUINEA-PIG AND HUMAN SKINS
    International journal of pharmaceutics
    
    E.M. Niazy, "DIFFERENCES IN PENETRATION-ENHANCING EFFECT OF AZONE THROUGH EXCISED RABBIT, RAT, HAIRLESS MOUSE, GUINEA-PIG AND HUMAN SKINS", International journal of pharmaceutics, 130(2), 1996, pp. 225-230
93. TSIMOYIANNIS EC; FLORAS G; ANTONIOU N; PAPANIKOLAOU N; TASSIS A
    LOW-MOLECULAR-WEIGHT HEPARINS AND DAFLON FOR PREVENTION OF POSTOPERATIVE THROMBOEMBOLISM
    World journal of surgery
    
    E.C. Tsimoyiannis et al., "LOW-MOLECULAR-WEIGHT HEPARINS AND DAFLON FOR PREVENTION OF POSTOPERATIVE THROMBOEMBOLISM", World journal of surgery, 20(8), 1996, pp. 968-972
94. EVANS MS; NARITOKU DK; COUCH JR; GHOBRIAL MW
    ONSET OF NEUROLOGIC DEFICITS AFTER TREATMENT WITH DIHYDROERGOTAMINE IN A PATIENT WITH SAGITTAL SINUS THROMBOSIS
    Clinical neuropharmacology
    
    M.S. Evans et al., "ONSET OF NEUROLOGIC DEFICITS AFTER TREATMENT WITH DIHYDROERGOTAMINE IN A PATIENT WITH SAGITTAL SINUS THROMBOSIS", Clinical neuropharmacology, 19(2), 1996, pp. 177-184
95. HORBACH T; WOLF H; MICHAELIS HC; WAGNER W; HOFFMANN A; SCHMIDT A; BECK H
    A FIXED-DOSE COMBINATION OF LOW-MOLECULAR-WEIGHT HEPARIN WITH DIHYDROERGOTAMINE VERSUS ADJUSTED-DOSE UNFRACTIONATED HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP-REPLACEMENT
    Thrombosis and haemostasis
    
    T. Horbach et al., "A FIXED-DOSE COMBINATION OF LOW-MOLECULAR-WEIGHT HEPARIN WITH DIHYDROERGOTAMINE VERSUS ADJUSTED-DOSE UNFRACTIONATED HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP-REPLACEMENT", Thrombosis and haemostasis, 75(2), 1996, pp. 246-250
96. PIERCE PA; XIE GX; PEROUTKA SJ; LEVINE JD
    DUAL EFFECT OF THE SEROTONIN AGONIST, SUMATRIPTAN, ON PERIPHERAL NEUROGENIC INFLAMMATION
    Regional anesthesia
    
    P.A. Pierce et al., "DUAL EFFECT OF THE SEROTONIN AGONIST, SUMATRIPTAN, ON PERIPHERAL NEUROGENIC INFLAMMATION", Regional anesthesia, 21(3), 1996, pp. 219-225
97. KALKMAN HO; SCHNEIDER F
    EFFECTS OF ERGOTAMINE AND DIHYDROERGOTAMINE ON 5-HYDROXYTRYPTAMINE-2ARECEPTORS IN THE ISOLATED RAT AORTA
    Pharmacology
    
    H.O. Kalkman e F. Schneider, "EFFECTS OF ERGOTAMINE AND DIHYDROERGOTAMINE ON 5-HYDROXYTRYPTAMINE-2ARECEPTORS IN THE ISOLATED RAT AORTA", Pharmacology, 53(6), 1996, pp. 351-355
98. GOBEL H; STOLZE H; HEINZE A; DWORSCHAK M; HEUSS D; CHRISTIANI K; LINDNER V
    18-MONTH LONG-TERM ANALYSIS OF THE EFFECT IVENESS, SAFETY AND TOLERABILITY OF SUBCUTANEOUS SUMATRIPTAN IN ACUTE MIGRAINE TREATMENT
    Nervenarzt
    
    H. Gobel et al., "18-MONTH LONG-TERM ANALYSIS OF THE EFFECT IVENESS, SAFETY AND TOLERABILITY OF SUBCUTANEOUS SUMATRIPTAN IN ACUTE MIGRAINE TREATMENT", Nervenarzt, 67(6), 1996, pp. 471-483
99. CAPOBIANCO DJ; CHESHIRE WP; CAMPBELL JK
    AN OVERVIEW OF THE DIAGNOSIS AND PHARMACOLOGICAL TREATMENT OF MIGRAINE
    Mayo Clinic proceedings
    
    D.J. Capobianco et al., "AN OVERVIEW OF THE DIAGNOSIS AND PHARMACOLOGICAL TREATMENT OF MIGRAINE", Mayo Clinic proceedings, 71(11), 1996, pp. 1055-1066
100. MOUBARAK AS; PIPER EL; JOHNSON ZB; FLIEGER M
     HPLC METHOD FOR DETECTION OF ERGOTAMINE, ERGOSINE, AND ERGINE AFTER INTRAVENOUS-INJECTION OF A SINGLE-DOSE
     Journal of agricultural and food chemistry
     
     A.S. Moubarak et al., "HPLC METHOD FOR DETECTION OF ERGOTAMINE, ERGOSINE, AND ERGINE AFTER INTRAVENOUS-INJECTION OF A SINGLE-DOSE", Journal of agricultural and food chemistry, 44(1), 1996, pp. 146-148